iFirst Medical Technologies

Providing a new standard-of-care in coagulation diagnostics. Modernized coagulation testing that can characterize patient physiological data such as anticoagulants, ethnicity and care history. Existing tests such as PT/INR do not provide the sensitivity or depth of information needed in critical care applications such as traumatic injury or surgical monitoring. Simple to use, mobile and inexpensive; iFirst's "mobile lab" will enable lifesaving information to be transmitted to the hospital prior to patient arrival. Blood products can be selected as the patient is en-route. iFirst envisions the growth of products using a mobile health diagnostic platform and continues to pursue its application for other critical situations; where ease of use, cost, and mobility can help save lives of patients and provide care-providers increase profits.

• Employees 5
• Founded 2016
• Total Funding $150455